Not yet recruiting
An Open-Label Trial of Veligrotug in Participants With Thyroid Eye Disease Who Previously Responded to Teprotumumab
NCT07832136
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- Office of Dr. Amy Patel Jain, MD Newport Beach, California, United States
- Sarasota Retina Institute Sarasota, Florida, United States
- Ophthalmic Consultants of Boston East Weymouth, Massachusetts, United States
- Kahana Oculoplastic & Orbital Surgery Livonia, Michigan, United States